Papers › Biomedical NER for the Enterprise with Distillated BERN2 and the Kazu Framework

Biomedical NER for the Enterprise with Distillated BERN2 and the Kazu Framework

1 Dec 2022arXiv:2212.00223archive 2025-07-28

Wonjin Yoon, Richard Jackson, Elliot Ford, Vladimir Poroshin, Jaewoo Kang

In order to assist the drug discovery/development process, pharmaceutical companies often apply biomedical NER and linking techniques over internal and public corpora. Decades of study of the field of BioNLP has produced a plethora of algorithms, systems and datasets. However, our experience has been that no single open source system meets all the requirements of a modern pharmaceutical company. In this work, we describe these requirements according to our experience of the industry, and present Kazu, a highly extensible, scalable open source framework designed to support BioNLP for the pharmaceutical sector. Kazu is a built around a computationally efficient version of the BERN2 NER model (TinyBERN2), and subsequently wraps several other BioNLP technologies into one coherent system. KAZU framework is open-sourced: https://github.com/AstraZeneca/KAZU

PaperPDFCode

In Syntology View this paper on Syntology, its page in Syntology's graph. That page lists the repositories linked to the paper, the abstract and the calls for agents.

Open this paper in Syntology's Atlas, the map of the papers in Syntology's graph and their citations.

For agents, on Syntology's MCP service (how to connect):

Code

astrazeneca/kazu officialmentioned in paperjaxApache-2.0Syntology: no sample linked to this paper (harvested for another paper). Syntology's graph links these samples to Stanza: A Python Natural Language Processing Toolkit for Many Human Languages (arXiv:2003.07082; that paper's own run record: 16 ran (of which 8 constructed an object rather than computing a result; 10 with no instrument failure: 2 honoured, 0 violated, 8 with no contract checked; 6 where Syntology's instrument failed) · 14 unverified); nothing checks that they implement this paper's method. report

Repository list and official/mentioned flags are the archive's, frozen 2025-07-28. Reachability, where shown, is from one Syntology probe window (2026-09-16 to 2026-09-18); repositories not probed show nothing. GitHub stars are not tracked.

A paper named beside a repository with no sample linked to this paper is shown with that paper's own run record, not this paper's: “ran” means executed on a synthesized input, not that the code is correct, and “where Syntology's instrument failed” counts failures of Syntology's instrument, not of the code. Papers are listed in arXiv-id order, at most three per repository.

Code Syntology ran Syntology

Not run by Syntology. Nothing on this page verifies that the listed code works.

Tasks

Drug DiscoveryNER

Results from the paper archive 2025-07-28

No leaderboard rows for this paper in the archive.

Report a problem or propose a change · a person checks every report against the paper or source before anything changes; decisions are listed on /corrections